Finoriq research workspace
Allogene Therapeutics, Inc. (ALLO) Insider Transactions & Form 4 Activity
Track insider acquisitions, dispositions, options, RSUs, and Form 4 activity for Allogene Therapeutics, Inc. (ALLO).
Company Snapshot
Allogene Therapeutics, Inc. a clinical stage immuno-oncology company, develops and commercializes genetically engineered allogeneic T cell therapies for the treatment of cancer and autoimmune diseases. It develops a pipeline of multiple allogeneic CAR T cell product candidates utilizing protein engineering, gene editing, gene insertion, and advanced proprietary T cell manufacturing technologies. The company is also developing cemacabtagene ansegedleucel (cema-cel), an engineered allogeneic CAR T cell product candidate that targets CD19 for the treatment of large B-cell lymphoma (LBCL). In addition, it develops ALLO-316, an engineered allogeneic CAR T cell product candidate that targets CD70 to treat renal cell carcinoma (RCC); and ALLO-329, an engineered allogeneic CAR T cell product candidate that targets both CD19 and CD70 for the treatment of autoimmune diseases (AID), such as systemic lupus erythematosus (SLE), idiopathic inflammatory myopathies (IIM), and systemic sclerosis (SSc). The company was incorporated in 2017 and is headquartered in South San Francisco, California.
- Company
- Allogene Therapeutics, Inc. (ALLO)
- Ticker
- ALLO
- Market Cap
- $614.4M
- Latest Price
- $1.78
- Industry
- Biotech & Pharma
Allogene Therapeutics, Inc. (ALLO) Recent Insider Transactions
Recent market insider transaction records indexed for Allogene Therapeutics, Inc. (ALLO).
| Insider | Code | Value | Transaction Date |
|---|---|---|---|
| Yoshiyama AnnieSVP, Finance | S | Disposed | -$22,144 | 2026-04-21 |
| Beneski Benjamin MachinasSVP, Chief Technical Officer | S | Disposed | -$7,168 | 2026-03-31 |
| Beneski Benjamin MachinasSVP, Chief Technical Officer | S | Disposed | -$11,942 | 2026-03-16 |
| Chang David DPresident and CEO | S | Disposed | -$117,975 | 2026-03-16 |
| Beneski Benjamin MachinasSVP, Chief Technical Officer | S | Disposed | -$18,543 | 2026-03-02 |
Live data loads in the app
This static page shell gives search engines reliable page context. Current tables, filings, charts, and market data continue to load from Finoriq APIs after the application starts.